Health authorities in the Democratic Republic of the Congo are intensifying efforts to combat a rapidly expanding Ebola outbreak caused by the Bundibugyo strain of the virus. As confirmed cases surpass 4,000 and deaths reach approximately 1,800, officials from the Africa Centres for Disease Control and Prevention announced they are investigating whether the virus may be undergoing mutation, citing the unprecedented severity of the current outbreak compared to historical precedents.
The outbreak represents the second-largest Ebola crisis on record. Comparatively, it has generated eight times more cases and six times more deaths than were documented 11 weeks into the 2014-18 West Africa outbreak, which ultimately affected more than 28,000 individuals. Officials highlighted concerning transmission patterns, noting that more than two-thirds of deaths are occurring in community settings rather than in established treatment facilities, indicating substantial untracked spread.
Response strategies are shifting from contact tracing to active case identification, with community health workers planning systematic door-to-door searches in affected areas. Health officials acknowledged that current contact tracing efforts are inadequate, identifying only approximately 10 contacts per Ebola patient when the expected number is around 40. The outbreak is primarily concentrated in the conflict-affected mining province of Ituri but has extended to multiple provinces, with 20 cases previously recorded in neighbouring Uganda before containment.
Treatment approaches are expanding to include compassionate use of the antiviral medication remdesivir and potential deployment of the Ervebo vaccine, which preliminary data suggests may provide protection against the Bundibugyo strain despite being licensed for a different Ebola variant. Officials stressed that public health measures alone may be insufficient to control the outbreak’s trajectory, necessitating comprehensive community engagement and digital tools integration. Separately, disruptions to routine healthcare services have emerged as a secondary concern, with vaccination coverage rates declining significantly in affected regions due to infection fears and service interruptions.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI